NDC 70710-1221-01 - CARBIDOPA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1221
- Requested NDC
- 70710-1221-01
- Package NDCs from labels
- 70710-1221-1, 70710-1221-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2023-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CARBIDOPA - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1221-1 | CARBIDOPA | 100 in 1 BOTTLE | TABLET | 100 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1221 | CARBIDOPA TABLET [ZYDUS PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20230917_c0b1ef99-3092-431a-8fb6-897affd52595.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1221-1 | EA - Each | 70710-1221 | 743b5c3e-a5fd-42ee-b4c0-073005ef0c86 | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Sun Pharmaceutical Industries, Inc. | 48e0f2ec-b217-4c25-a71c-20e173d05edb | 2026-06-12 | Warnings, Adverse reactions | MNX7R8C5VO |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Sun Pharmaceutical Industries, Inc. | d2a64f14-f638-49d9-8a96-cb7ae46ac3ea | 2026-06-04 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | ScieGen Pharmaceuticals Inc | 1b17ab1e-f3c1-4343-ba28-e2901cd97d43 | 2026-06-01 | Warnings, Adverse reactions | MNX7R8C5VO |
| CREXONT | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 2026-05-29 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Major Pharmaceuticals | 3f6d393e-ac84-4a3c-a837-199d1ec71fd2 | 2026-05-28 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Westminster Pharmaceuticals, LLC | 3f026272-32a6-4c98-8b6f-d910c7f58aa2 | 2026-05-27 | Warnings, Adverse reactions | MNX7R8C5VO |
| Calamine | CALAMINE AND ZINC OXIDE | Pharma Nobis, LLC | fbcfa541-beda-06de-e053-6294a90a9298 | 2026-05-26 | Warnings | 1K09F3G675 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Dr. Reddy's Laboratories Inc | 87ab55c9-203d-d595-3e3e-0e38f2f6d9c4 | 2026-05-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | Advagen Pharma Ltd | 5b6519ff-d1af-402b-83eb-b4fce6743a18 | 2026-05-12 | Warnings, Adverse reactions | MNX7R8C5VO |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | CVS Pharmacy | db6f518d-3a0e-43f8-8d19-7382d9b7ff1c | 2026-05-11 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Retail Business Services, LLC | 7291e175-a9b6-4c47-93ce-227ce11e4599 | 2026-04-30 | Warnings, Adverse reactions | 1K09F3G675 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 4ce99f65-5857-448c-b22a-9b3b64de69e2 | 2026-04-29 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | ScieGen Pharmaceuticals Inc | a32afa84-7bc0-4bd3-bc50-55d738f3d7ce | 2026-04-27 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Pharmaceuticals Inc. | aa5028d6-fd0a-4cf1-b708-c93bb2a7c76a | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | b29e58f0-67b1-4036-a4a8-4915a8c13cdf | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | beedd327-bbc5-4f17-838a-4e72bf0867f0 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 57688b2c-7be0-4e73-9b4f-7ec3b5dc1c37 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 9ac804f1-7e15-48bc-8ae9-25181a629dd4 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Coupler LLC | 500f0cdb-10e1-9545-e063-6394a90a3ad1 | 2026-04-22 | Warnings, Adverse reactions | MNX7R8C5VO |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.